Article
Activation of the glmS Ribozyme Confers Bacterial Growth Inhibition.
Chembiochem : a European journal of chemical biology - 2 Mar 2017
Schüller Anna, Matzner Daniel, Lünse Christina E, Wittmann Valentin, Schumacher Catherine, Unsleber Sandra, Brötz-Oesterhelt Heike, Mayer Christoph, Bierbaum Gabriele, Mayer Günter
Abstract excerpt
The ever-growing number of pathogenic bacteria resistant to treatment with antibiotics call for the development of novel compounds with as-yet unexplored modes of action. Here, we demonstrate the in vivo antibacterial activity of carba-α-d-glucosamine (CGlcN). In this mode of action study, we provide evidence that CGlcN-mediated growth inhibition is due to glmS ribozyme activation, and we demonstrate that CGlcN...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
